Online Store: Webinar Recordings
Main Storefront
        

COGs Survey: Results and Red Flags - Digital Recording (November 5, 2013)

Item Options
Sign in for your pricing!
Price: $85.00
Quantity: *
 
Description

ISCT Webinar: COGs Survey: Results and Red Flags

Presented by the ISCT Business Model & COGs Sub-Committee 

Please open the PDF slides and click the link on the first page to access the Digital Recording.

 

Date: November 5th, 2013

Time: 12pm ET to 1:00pm ET

Chair: William Milligan, Chair, ISCT Business Models and COGs Subcommittee

Speaker(s): William Milligan, Robert Perry, Knut Niss, members, ISCT Business Models and COGs Subcommittee 

 

About the Webinar:

This webinar will review the results of the ISCT COGs Survey circulated to Membership in June, 2013. The COGs Survey explored a range of considerations for cell therapy manufacturing (both autologous and allogeneic) as it relates to managing COGs (cost of goods). The goal of the survey was to gain better knowledge of current practices and experience in cell therapy manufacturing development. Understanding where cell therapy manufacturing standards are today, will help guide the drafting of a COGs white paper to provide a road map of considerations and resources for manufacturing / COGs planning and decision making. This is a key strategic discipline for developing cell therapies with the goal of optimal pricing, for broad adoption and reimbursement, leading to successful commercialization.

Join members of the ISCT Business Models and COGs subcommittee as they review the results and key learning gained from the responses. The committee will identify areas of focus for cost of goods considerations and introduce future plans for addressing the needs identified.

© 2015 International Society for Cellular Therapy. All rights reserved.
ISCT, International Society for Cellular Therapy, and the ISCT logo are registered service marks of The International Society for Cellular Therapy.
The BEACON and lighthouse logo is a service mark of The International Society for Cellular Therapy.